Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03883269 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 20, 2019 (before its estimated June 2019 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
The combined bacteriostatic and immunomodulatory effects of erythromycin and clindamycin will be explored. Treatment effects will be extensively characterized by conventional methods including lesion counts, global assessment scales and visual grading as well as state-of-the-art methodology, including multi-modal photo analysis, perfusion by laser speckle contrast imaging, analysis of local skin surface, biopsy biomarkers and skin microbiota. This extensive response profiling, combined with the mechanistic insights from concurrent in vitro and in vivo studies in healthy volunteer challenges, will increase the understanding of erythromycin's and clindamycin's effects in acne vulgaris.
Trial Details
NCT Number NCT03883269
Lead Sponsor Centre for Human Drug Research, Netherlands
Collaborators: Maruho Co., Ltd.
Conditions
(from sponsor)
Acne Vulgaris
Related terms Acne Vulgaris
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov